Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Halawah HH, Alkhatib NS, Almutairi AR, Saleh M, Halloush SS, Rashdan O, Masadh L, Abusara OH, Abraham I. Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan. J Med Econ 2023:1-31. [PMID: 37318242 DOI: 10.1080/13696998.2023.2226007] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]

Number

Cited by Other Article(s)

Abraham I, Hiligsmann M, Lee KKC, Citrome L, Colombo GL, Gregg M. What to expect in 2024: important health economics and outcomes research (HEOR) trends. Curr Med Res Opin 2024;40:185-192. [PMID: 38122828 DOI: 10.1080/03007995.2023.2291603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]

Abraham I, Hiligsmann M, Lee KKC, Citrome L, Colombo GL, Gregg M. What to expect in 2024: important health economics and outcomes research (HEOR) trends. J Med Econ 2024;27:69-76. [PMID: 38122829 DOI: 10.1080/13696998.2023.2291604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]

Abraham I, Hiligsmann M, Lee KKC, Citrome L, Colombo GL, Gregg M. What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends. Clinicoecon Outcomes Res 2023;15:799-809. [PMID: 38274129 PMCID: PMC10810314 DOI: 10.2147/ceor.s453171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 12/08/2023] [Indexed: 01/27/2024] Open

Abraham I, Hiligsmann M, Lee KKC, Citrome L, Colombo GL. What to expect in 2024: important health economics and outcomes research (HEOR) trends. Expert Rev Pharmacoecon Outcomes Res 2023:1-8. [PMID: 38126707 DOI: 10.1080/14737167.2023.2292838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]

Abraham I. Preparing for the third decade of biosimilars. Expert Opin Biol Ther 2023;23:651-652. [PMID: 37574709 DOI: 10.1080/14712598.2023.2247916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Accepted: 08/08/2023] [Indexed: 08/15/2023]